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Background:   Following passage of the Affordable Care Act, 30-day readmissions have come 
under greater scrutiny, with penalties levied for higher than expected readmission rates. We 
examined risk factors for 30-day readmission following colorectal resection and evaluated the 
financial impact of readmissions on the healthcare system. 
 
Methods: The University HealthSystem Consortium Clinical Database was queried for adults 
undergoing colorectal surgery for cancer, diverticular disease, inflammatory bowel disease, or 
benign tumors from 2008-2012.  Predictors of 30-day readmission were assessed with 
multivariable logistic regression. Additional endpoints included time to readmission, readmission 
diagnosis, readmission length of stay (LOS), and readmission cost. 
 
Results:  A total of 70,484 patients met study inclusion criteria, 13.7% (9,632) of which were 
readmitted within 30 days of discharge.  The strongest independent predictors of readmission 
were: LOS ≥4 days (OR 1.44; 95% CI 1.32-1.57), stoma (OR 1.54; 95% CI 1.46-1.51), and non-
home discharge (OR 1.68; 95% CI 1.57-1.81).   Of those readmitted, half occurred within 7 
days, 13% required ICU care, 6% had a reoperation, and 2% died during the readmission stay.  
The median combined total direct hospital cost was over two times higher ($26,917 v. $13,817; 
p<0.001) than non-readmitted patients.  Compared with late readmissions, those readmitted 
within 7 days were more likely to have a reoperation (8% v. 4%, p<0.001), be admitted to the 
ICU (14% vs. 12%, p<0.001), and had a longer median readmission LOS (5d vs. 4d, p<0.001). 
 
CONCLUSIONS:  30-day readmissions following colorectal resection occur frequently and incur 
a significant financial burden on the healthcare system.  Highest-risk patients include those with 
longer LOS, stoma, and non-home discharge. Future studies aimed at targeted interventions 
may reduce readmissions and curb escalating healthcare costs.  
 
